HOME >> MEDICINE >> NEWS
Novel neurotransmitter overturns laws of biology, offers potential for stroke treatment

" this...could put researchers on the royal road to stroke treatment."

Johns Hopkins scientists have identified a new and unusual nerve transmitter in the brain, one that overturns certain long-cherished laws about how nerve cells behave.

Reporting in the current Proceedings of the National Academy of Sciences, the team led by neuroscientist Solomon H. Snyder, M.D., has also pinpointed the neurotransmitter's source -- itself a biologically unusual enzyme -- whose novelty as a drug target "could put researchers on a royal road to stroke treatment."

The neurotransmitter is an amino acid called D-serine. It's odd, Snyder says, because it differs in structure from any known molecule in its class found in mammals and other higher animals. D-serine is what chemists call a right handed amino acid. Normally, amino acids have atoms that extend from the left side of the molecule. These L-amino acids, as they're called, are the rule in vertebrates, whose biochemistry is set up to deal with these forms.

Some primitive organisms, however, notably bacteria, have a mixture of both L-amino acids and their mirror images called D-amino acids. But to find a D-amino acid in humans, Snyder says, "is unprecedented;" it's the equivalent of finding a Pterodactyl in your local pet shop.

Moreover, unlike dopamine, serotonin or other traditional nerve transmitters, D-serine isn't secreted at nerve cell endings in the brain. Instead, it comes from adjacent cells called astrocytes, which enclose nerve cells in the brain's gray matter like a glove.

The current study adds conclusive evidence to the idea that D-serine -- released from astrocytes -- activates receptors on key nerve cells in the brain. Activating these receptors, called NMDA receptors, has long been linked with learning, memory and higher thought. NMDA receptors are also known culprits in stroke damage in the brain, and have become a focus for anti-stroke research.

A body of work a
'"/>

Contact: Marjorie Centofanti
mcentofanti@jhmi.edu
410-955-8725
Johns Hopkins Medical Institutions
8-Nov-1999


Page: 1 2 3

Related medicine news :

1. Novel therapy tested in mice could chase away cat allergies
2. Novel antibiotic shows promise in shortening treatment duration of tuberculosis
3. Novel p53 gene-based therapy boosts immune system and reduces tumor size
4. Novel drugs help solve Gleevec resistance
5. Novel imaging technique shows abnormal brain anatomy in children with ADHD
6. Novel drug-antidote strategy provides greater control of drug action
7. Novel imaging technique shows lymph nodes, metastases in breast cancer without surgery
8. Novel delivery method for nutrients wins Kaye Innovation Award for Hebrew university students
9. Novel vitamin discovery offers clues for cancer chemotherapy and lipid disorders
10. Novel findings about neovessel formation
11. Novel MRI technique provides clear images of blood flow

Post Your Comments:
(Date:5/23/2013)... Looking for tips on how to avoid ... of caring for your aging parent? Today the ... released the results of a survey of 335 geriatric care ... , Here are the top 5 tips identified by these ... survey respondents selecting each option): , 1.    Give each family member ...
(Date:5/23/2013)... 23 May 2013.- CNIC researchers have discovered that the ... release of hematopoietic stem cells from the bone marrow ... in the journal Cell ., Neutrophils are leukocytes ... from bacteria and other disease organisms. To perform their ... into contact with microorganisms. However, release of these substances ...
(Date:5/23/2013)... 2013 A medical Internet marketing consulting ... Targeting members of the medical and healthcare community to ... patients, the consulting service is focused on SEO and ... medical Internet marketing agency is providing the service to ... As part of the consulting, the company will draw ...
(Date:5/23/2013)... HOLLOW, NY (PRWEB) May 23, 2013 ... the staff of Phelps Memorial Hospital Center as Medical ... She will direct comprehensive inpatient and outpatient rehabilitation care ... , Dr. Liu received her undergraduate degree in biochemistry ... for four years. She earned her medical degree ...
(Date:5/23/2013)... -- Mild to moderate iodine deficiency during pregnancy may ... British researchers report. Low levels of the so-called ... put her child at risk of poorer verbal and ... found. Pregnant women can boost their iodine levels by ... The finding, published online May 22 in ...
Breaking Medicine News(10 mins):Health News:New Survey of Aging Experts Gives Top 5 Tips for Avoiding Family Feud when Caring for Aging Parents 2Health News:Discarded immune cells induce the relocation of stem cells 2Health News:Healthcare Internet Marketing Consulting Services Launched by JD Media Surge 2Health News:Wei Angela Liu, MD, Named Head of Physical Medicine and Rehabilitation at Phelps Memorial Hospital Center in Sleepy Hollow, New York 2Health News:Low Prenatal Iodine May Affect Child's Brain Development 2
(Date:5/23/2013)... -- Omeros Corporation (NASDAQ: OMER ) today ... to evaluate OMS824 in Huntington,s disease has been ... (FDA). OMS824 selectively inhibits phosphodiesterase 10 (PDE10), an ... to a wide range of diseases that affect ... shown promising results in animal models directly relevant ...
(Date:5/23/2013)... , May 23, 2013  Inhibikase Therapeutics, Inc., ... today that it will present new results on ... industry conference sponsored by the PML Consortium (composed ... JC polyomavirus (JCV) is the causative agent of ... kinase inhibitor in an extended release formulation, can ...
(Date:5/23/2013)... -- InspireMD, Inc. ("InspireMD" or the ... protection stents, today announced new 6-month results from ... trial demonstrating that the MGuard Embolic Protection Stent ... in all-cause mortality in ST segment elevation myocardial ... presented at the InspireMD STEMI Symposium at EuroPCR, ...
Breaking Medicine Technology:Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4Inhibikase Therapeutics to present at Industry Conference on Drug-Induced Progressive Multifocal Leukoencephalopathy (PML) 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 3InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 4InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 5
Cached News: